On the upside
Immunomedics (Nasdaq: IMMU) reported positive results from a Phase IIb clinical trial for its lupus treatment.
Former American International Group (NYSE: AIG) chief executive Maurice Greenberg expressed a willingness to assist new chief executive Robert Benmosche.
Oshkosh (NYSE: OSK) landed a $280.9 million contract to supply the U. S. Army with 2,568 trucks and trailers.
On the downside
Clayton, Dubilier & Rice's $250 million investment in NCI Building Systems (NYSE: NCI) has been delayed.
A class action lawsuit was filed against CardioNet (Nasdaq: BEAT) on behalf of stock purchasers between April 30, 2009 and June 30, 2009.
Johnson & Johnson (NYSE: JNJ) ended its development of Alkermes' (NYSE: ALKS) month long version of its antipsychotic treatment risperidone.
In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE and by more than 5 to 2 on Nasdaq. The Russell 2000 which tracks small cap stocks fell 7 points to 577.
